Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3162
Selected: 0
NCT IDTitle
NCT03591094Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis
NCT05425576OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition
NCT06613360A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
NCT03544060Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)
NCT04855760Safety of REL-1017 for Major Depressive Disorder
NCT07019194An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition
NCT06994676A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
NCT03540160Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
NCT01831960An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris
NCT05859776Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
NCT01069094A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
NCT02414594Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)
NCT05375994Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients
NCT07052760Imaging of Solid Tumors Using DLL3 SPECT
NCT05540860A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
NCT04860960Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
NCT04976660TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
NCT06097260Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT01789476A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery
NCT04572776Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
NCT05117476A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
NCT06923527ctDNA Guided Adjuvant Treatment With Elacestrant: TBCRC-068
NCT05724576Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients
NCT01813227A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
NCT03594227ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
NCT04990427CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT03126227Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
NCT04906876A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
NCT01991327Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males
NCT02044627Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002
NCT05812027A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
NCT03910660A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
NCT04022876A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
NCT06410976Prospective Clinical Assessment Study in Children With Hypochondroplasia
NCT03900676Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris
NCT05060276Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors
NCT06500676A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
NCT00511576Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors
NCT04485260An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
NCT04355676Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19
NCT04683627A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee
NCT05391048An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition
NCT01954030Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure
NCT00474630A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
NCT00765648Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department
NCT02117830A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
NCT05010174Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
NCT03606174A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma
NCT05935774OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
NCT04621630Pharmacokinetics of PN-235 in Healthy Volunteers